Will Pass, DVM | Authors


FDA Issues Draft Guidance to Broaden Clinical Trial Inclusion

June 19, 2019

The FDA recently released 5 new draft guidance documents that promote broader patient eligibility for cancer clinical trials. The policies encourage inclusion of certain individuals who were previously disqualified due to medical conditions or biological factors, including brain metastases, organ dysfunction, prior or concurrent malignancies, chronic infections, and age.